Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors
Witkowska, M.
Kardiologia Polska 25(2): 147-161
1982
ISSN/ISBN: 0022-9032 PMID: 6125621 Document Number: 187213
Document emailed within 1 workday
Related Documents
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Sharma, P.L. 1976: Clinical pharmacology of adrenergic beta-receptor blocking drugs Journal of the Association of Physicians of India 24(11): 729-735
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Rahn, K.H. 1975: Clinical pharmacology of anti-arrhythmia agents Medizinische Klinik 70(23): 994
Azanza Perea, J.R.; Honorato Pérez, J.M.; Cuena Boy, R. 1984: Clinical pharmacology of anti-arrhythmia agents Revista de Medicina de la Universidad de Navarra 28(1): 37-43
Zeng, G.Y. 1983: Clinical pharmacology of anti-arrhythmia agents Zhonghua Xin Xue Guan Bing Za Zhi 11(1): 15-19
Panizon, F. 1977: Round table discussion on recent progress in the use of adreno-blocking and adreno-stimulating drugs. Introduction. General concepts concerning the pharmacology and physiopathology of the adrenergic receptors Minerva Pediatrica 29(7): 371-378
Witkowska, M. 1981: Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide Kardiologia Polska 24(7): 505-517
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Slawin, S. 1973: Beta adrenergic blocking drugs Harefuah 85(4): 178-183
Canale, J.M.; Horwitz, S. 1979: Therapeutic scope of beta-adrenergic blocking agents Archivos de Investigacion Medica 10(4): 261-277
Giudicelli, J.F. 1980: Pharmacology of beta adrenergic inhibing agents Therapie 35(1): 23-43
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Walters, L.; Dormehl, I.; Goosen, D.J.; Avenant, J.C.; Du Plessis, M.; Jacobs, N.; Schoeman, H.S. 1983: Beta-adrenergic blocking drugs and renal function South African Medical Journal 64(15): 572-573
Singh, B.N. 1973: Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 1. Pattern of response of common arrhythmias New Zealand Medical Journal 78(504): 482-486
Tafreshi, M.J.; Weinacker, A.B. 1999: Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma PharmacoTherapy 19(8): 974-978
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492
Madan, B.R.; Gupta, R.S. 1970: Effect of adrenergic beta receptor blocking agents on cardiac output Indian Heart Journal 22(2): 70-72